Osteoporosis-Treated Adults Have Elevated Risk of Mortality

This article originally appeared here.
Share this content:
Osteoporosis-Treated Adults Have Elevated Risk of Mortality
Osteoporosis-Treated Adults Have Elevated Risk of Mortality

FRIDAY, Feb. 13, 2015 (HealthDay News) -- Women and men below age 70 who are treated for osteoporosis have an excess mortality risk, according to a study published online Feb. 7 in the Journal of Bone and Mineral Research.

Bo Abrahamsen, M.D., Ph.D., from Glostrup Hospital in Denmark, and colleagues conducted an observational study tracking prescriptions for osteoporosis drugs, comorbid conditions, and deaths. Data were included for 58,637 patients and 225,084 age- and gender-matched controls. Patients were followed until the end of 2013, for a follow-up period of 10 to 17 years.

The researchers found that the relative risk of dying decreased from being strongly elevated in the first year to a stable but elevated level in subsequent years among men below age 80 and women below age 60. There was only a small increase in risk in the first year of treatment for women aged older than 65 to 70 years, followed by mortality that was lower than background mortality. For a 50-year-old man beginning osteoporosis treatment, the residual life expectancy was estimated at 18.2 years, whereas for a 75-year-old man it was 7.5 years. For women, the corresponding residual life expectancy numbers were estimated at 26.4 and 13.5 years.

"This study shows an excess mortality in men and in women below age 70 who are treated for osteoporosis, compared with the background population," the authors write. "This excess risk is more pronounced in the first few years on treatment."

The study was funded by Novartis, Nycomed/Takeda, NPS Pharmaceuticals, and Amgen; two authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WPSI Recommends Annual Urinary Incontinence Screening

WPSI Recommends Annual Urinary Incontinence Screening

Due to limited evidence, other experts urge caution in implementing guideline for women

Young, Growing Athletes at High Risk for ACL Injuries

Young, Growing Athletes at High Risk for ACL ...

Athletic teams should provide program that includes muscle strengthening, proper technique training

Side Effects of Biologics for Rheumatic Dz May Up Anxiety

Side Effects of Biologics for Rheumatic Dz May ...

Common patient concerns are risks of cancer and tuberculosis activation

is free, fast, and customized just for you!




Already a member?

Sign In Now »